1-4 of 4
Mototsugu Shimokawa, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and Efficacy of a Switch to Nilotinib in Patients with CML-CP Showing MMR to Imatinib: Results of a Multicenter Phase II Trial (NILSw Trial)

Hirohiko Shibayama, MD PhD, Tatsuya Kawaguchi, MD PhD, Junya Kuroda, MD PhD, Hirohisa Nakamae, MD PhD, Itaru Matsumura, MD PhD, Toshihiro Miyamoto, MD PhD, Jun Ishikawa, MD PhD, Tomohiko Kamimura, MD PhD, Kentaro Fukushima, MD PhD, Yutaka Imamura, MD PhD, Tetsuya Eto, MD PhD, Kazutaka Sunami, MD PhD, Mototsugu Shimokawa, PhD, Koichi Akashi, MD PhD, Yuzuru Kanakura, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1914.
https://doi.org/10.1182/blood.V128.22.1914.1914
Published: 2016
Journal Articles

Impact of Chromosomal Abnormalities in Acute and Lymphoma Types Adult T-Cell Leukemia-Lymphoma

Nobuaki Nakano, MD, Hiroo Katsuya, MD PhD, Takahiro Itoyama, MD, PhD, Mototsugu Shimokawa, PhD, Atae Utsunomiya, MD, PhD, Shuichi Hanada, MD, PhD, Tetsuya Eto, MD PhD, Yukiyoshi Moriuchi, MD, Yoshio Saburi, MD PhD, Masaharu Miyahara, MD, PhD, Eizaburo Sueoka, MD, PhD, Naokuni Uike, MD, PhD, Shinichiro Yoshida, MD, PhD, Kiyoshi Yamashita, MD, PhD, Kunihiro Tsukasaki, MD, Hitoshi Suzushima, MD, PhD, Yuji Ohno, MD, PhD, Junji Suzumiya, MD PhD, Kazuo Tamura, MD, PhD, Kenji Ishitsuka, MD, PhD
Journal: Blood
Blood (2016) 128 (22): 4123.
https://doi.org/10.1182/blood.V128.22.4123.4123
Published: 2016
Journal Articles

Discontinuation of Nilotinib in Patients with Chronic Myeloid Leukemia Who Have Maintained Deep Molecular Responses for at Least 2 Years: A Multicenter Phase 2 Stop Nilotinib (Nilst) Trial

Norimitsu Kadowaki, MD PhD, Tatsuya Kawaguchi, MD PhD, Junya Kuroda, MD PhD, Hirohisa Nakamae, MD PhD, Itaru Matsumura, MD PhD, Toshihiro Miyamoto, MD PhD, Jun Ishikawa, MD PhD, Koji Nagafuji, MD PhD, Yutaka Imamura, MD PhD, Hirohito Yamazaki, Mototsugu Shimokawa, PhD, Koichi Akashi, MD PhD, Yuzuru Kanakura, MD PhD
Journal: Blood
Blood (2016) 128 (22): 790.
https://doi.org/10.1182/blood.V128.22.790.790
Published: 2016
Journal Articles

Allogeneic Peripheral Blood Stem Cell Transplantation Using Reduced-Intensity Conditioning Regimen with Fludarabine and Busulfan from HLA-Matched Related Donor for Elderly Adult T-Cell Leukemia/Lymphoma: Results of Multicenter Phase II Study (ATL-NST-3)

Ryuji Tanosaki, MD PhD, Ilseung Choi, MD, Mototsugu Shimokawa, PhD, Atae Utsunomiya, MD PhD, Masahito Tokunaga, MD, Nobuaki Nakano, MD, Takahiro Fukuda, MD, Hirohisa Nakamae, Shigeki Takemoto, MD PhD, Shigeru Kusumoto, MD PhD, Takeaki Tomoyose, Eisaburo Sueoka, MD PhD, Motoaki Shiratsuchi, Youko Suehiro, MD, Takeharu Yamanaka, PhD, Jun Okamura, MD, Naokuni Uike
Journal: Blood
Blood (2014) 124 (21): 2580.
https://doi.org/10.1182/blood.V124.21.2580.2580
Published: 2014